DRKS00000799
Completed
Not Applicable
Study of interstitial lung disease in primary antibody deficiency - STILPAD
niversitätsklinikum FreiburgCentrum für Chronische Immundefizienz (CCI)0 sites150 target enrollmentJune 28, 2012
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- D83.9
- Sponsor
- niversitätsklinikum FreiburgCentrum für Chronische Immundefizienz (CCI)
- Enrollment
- 150
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of CVID according to ESID/PAGID criteria; Interstitial lung disease or granuloma diagnosed by chest CT positive for nodules, lines or ground\-glass signs; Signed written informed consent.
Exclusion Criteria
- •Patient without legal capacity who is unable to understand the nature, significance and consequences of the study; No written consent available.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A retrospective study of interstitial lung disease due to EGFR tyrosine kinase inhibitor and immune checkpoint inhibitornon-small cell lung cancerJPRN-UMIN000034321Juntendo University235
Not yet recruiting
Not Applicable
POPLAR studyPulmonary hypertension, Interstitial lung diseaseD006976, D017563JPRN-jRCT1010230018Tsujino Ichizo250
Recruiting
Not Applicable
Pulmonary involvement (interstitial lung disease of known etiology) in patients with Seropositive and ACPA positive Rheumatoid Arthritis (RA-ILD I and II)Early detection of lung involvement in RAM05.9M05.1J99.0Seropositive rheumatoid arthritis, unspecifiedRheumatoid lung diseaseDRKS00028871Boehringer Ingelheim Pharma GmbH & Co. KG200
Completed
Not Applicable
The COLDICE Trial: Cryobiopsy versus Open Lung biopsy in the Diagnosis of Interstitial lung disease allianCEInterstitial Lung DiseaseRespiratory - Other respiratory disorders / diseasesACTRN12615000718549auren Troy65
Recruiting
Not Applicable
An Observational Cohort Study of Interstitial Lung Abnormalities (ILAs) in a Large Japanese Health Screening Population (Kumamoto ILA study in Japan: KILA-J)Progressive fibrosing interstitial lung diseases including idiopathic pulmonary fibrosisJPRN-UMIN000045149Department of Respiratory Medicine Kumamoto University Medical Sciences1,500